Applications of Benzyl N-(2-Hydroxyethyl)Carbamate in Industrial Manufacturing

As a specialized manufacturer, we supply Benzyl N-(2-Hydroxyethyl)Carbamate exclusively for downstream industries with established, validated uses. Our material meets stringent production needs, supporting performance, safety, and regulatory compliance across targeted sectors. Below outlines key application scenarios, with critical details on compliance, dosage, integration points, and finished product forms.

1. Pharmaceutical Intermediate for Beta-lactam Antibiotic Synthesis

Within the pharmaceutical sector, this compound functions as an N-protecting agent in the synthesis of advanced beta-lactam antibiotics, supporting side-chain modifications and coupling steps under mild conditions. Downstream API manufacturers rely on its reactivity to preserve amine functional groups during the assembly of cephalosporin and penem structures. Strict manufacturing protocols, including in-process checks and traceability, govern its incorporation.

Industry compliance standards

• Good Manufacturing Practice (GMP) as per ICH Q7, EU GMP, and FDA 21 CFR Part 210/211
• European Pharmacopoeia & USP for starting and intermediate materials
• REACH Registration (EU)
• ICH Q3A (Impurities in New Drug Substances)

Typical usage ratio

• 0.5–1.2 molar equivalents relative to target amine substrates; precise quantities depend on substrate reactivity and scale

Downstream process integration

• Added during N-protection and deprotection stages in multi-step chemical synthesis; integrated after initial amination and prior to side-chain coupling

Final product types

• Active Pharmaceutical Ingredients (APIs) such as cephalosporin and carbapenem antibiotics
• Sterile injectable formulations following further purification

2. Peptide Synthesis Auxiliary in API Process Development

Peptide manufacturers incorporate Benzyl N-(2-Hydroxyethyl)Carbamate as a temporary carbamate protecting group to mask amine functionalities during solid-phase and solution-phase synthesis routes. It facilitates higher product purity by minimizing side reactions in sequential condensation steps, and removal of the group occurs under selective hydrogenolysis or acidolysis tailored to downstream requirements.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, FDA/EU)
• ICH Q11 (Development and Manufacture of Drug Substances)
• ICH Q8 (Pharmaceutical Development)
• Guidance for Industry: Process Validation (FDA)

Typical usage ratio

• 0.9–1.3 equivalents per protected amine site; optimization based on peptide chain length and protection strategy

Downstream process integration

• Applied at the initial amino acid derivatization or as a post-coupling protection step; removed before final purification and lyophilization

Final product types

• Therapeutic peptide APIs (e.g., peptide hormones, enzyme inhibitors)
• Lyophilized peptide bulk intermediates

3. Stabilizing Agent in Biochemical Reagent Formulation

Producers of laboratory biochemical reagents utilize this material to stabilize sensitive amine-based chemistries in diagnostic buffer and test kit formulations, preventing unwanted side reactions during shipping and storage. The carbamate forms reversible adducts with nucleophilic groups, maintaining reagent stability until end-user activation.

Industry compliance standards

• ISO 13485 (Medical Device Quality Management Systems) as applicable to diagnostic reagent supply
• OECD Good Laboratory Practice (GLP)
• REACH (EU Chemical Safety Legislation)

Typical usage ratio

• 0.05–0.15% w/w in diagnostic and biochemical reagent premixes, adjusted for amine content and target shelf life

Downstream process integration

• Mixed into aqueous or lyophilized buffer systems immediately prior to sterile filtration; in some cases, included during component compounding for stability trials

Final product types

• Clinical diagnostic kits (enzyme substrate solutions, calibration buffers)
• Research reagent sets for academic and industrial laboratories

4. Chemical Intermediate for Agrochemical Active Ingredient Modification

Agrochemical formulators employ Benzyl N-(2-Hydroxyethyl)Carbamate as a reactive masking group for primary and secondary amines when engineering novel herbicide or fungicide actives, enabling controlled group introduction before downstream hydrolysis or substitution. This selective blocking step supports the synthesis of amine-derived actives by controlling unwanted side reactions during multi-functionalization.

Industry compliance standards

• ISO 9001 (Quality Management Systems for agro ingredient production)
• FAO/WHO Guidelines for Active Ingredient Manufacturing
• REACH (for ingredient toxicology and use restrictions)

Typical usage ratio

• One molar equivalent per reactive amine group introduced; tailored further to target active structure and reactivity profile

Downstream process integration

• Applied during the amine protection phases prior to main transformation reactions; typically cleaved at the penultimate synthesis stage prior to formulation

Final product types

• Technical grade pesticide or fungicide actives
• Formulated crop protection products provided as granules, powders, or emulsifiable concentrates

5. Sourcing Intermediate for Fine Chemical Custom Synthesis

Contract and custom fine chemical manufacturers integrate this compound as a modular protecting group during the multi-step assembly of specialty molecules, including chiral ligands and advanced monomers for electronics. Its utility derives from unique deprotection selectivity and compatibility with diverse reaction conditions, addressing project-specific synthetic requirements without compromising subsequent chemistries.

Industry compliance standards

• ISO 9001 (Quality Management)
• REACH (Europe)
• Compliance with contract-specific QC protocols

Typical usage ratio

• Custom-proportioned from 0.4–1.0 equivalents based on order-specific synthesis routes; defined jointly by customer and QC teams

Downstream process integration

• Introduced following substrate preparation; removed by catalytic hydrogenolysis or acidolysis at the designated synthesis step, often prior to final assembly or purification

Final product types

• Chiral building blocks for catalysts or pharmaceuticals
• Specialty monomers for electronic materials (e.g., OLED, semiconductors)
• Intermediates for advanced additive manufacturing feedstocks